Key result
LV end-diastolic dimension ≤61 mm predicted tachycardia-induced cardiomyopathy versus idiopathic DCMP with 100% sensitivity and 71.4% specificity (OR 0.742 per 1 mm; 95% CI 0.618-0.891; p=0.001).
Why the study?
Does initial echocardiographic assessment differentiate tachycardia-induced cardiomyopathy from idiopathic dilated cardiomyopathy, and is rate control as effective as rhythm control for EF improvement?
Case-Control (n=42)
Does initial echocardiographic assessment differentiate tachycardia-induced cardiomyopathy from idiopathic dilated cardiomyopathy, and is rate control as effective as rhythm control for EF improvement?
Initial echocardiographic parameters, specifically LV end-diastolic dimension <=61 mm, can accurately differentiate tachycardia-induced cardiomyopathy from idiopathic dilated cardiomyopathy, and rate control is as effective as rhythm control for EF recovery.
LV end-diastolic dimension may aid differentiation of tachycardia-induced cardiomyopathy; hypothesis-generating and requires prospective validation.
BACKGROUND: Due to the absence of differential guidelines for heart failure with tachyarrhythmia, it is difficult to diagnose tachycardia-induced cardiomyopathy (TIC) at the initial visit. Furthermore, clinical outcomes of rate versus rhythm control in TIC are unclear. HYPOTHESIS: Because the etiology of TIC is different from dynamic cardiomyoplasty (DCMP), differential parameters may be present. METHODS: We assessed 21 patients with TIC (15 men; mean age, 50+/-14 years) and 21 control patients with idiopathic DCMP. We assessed clinical courses, echocardiographic parameters, as well as outcomes by treatment. RESULTS: In the TIC group, the related tachyarrhythmias were atrial fibrillation (n=12), atrial flutter (n=5), atrial tachycardia (n=3) and paroxysmal supraventricular tachycardia (n=1). After treatment, all patients became asymptomatic and the ejection fraction (EF) improvement (DeltaEF>or=15%) was observed in all patients (left ventricular ejection fraction [LVEF], 30+/-11%initial versus 58+/-6%last). In the idiopathic DCMP group, no patient showed EF improvement (EF increase<or=5%), and 4 patients (19%) underwent heart transplantation. Left ventricle (LV) mass indices, volumes adjusted by BSA, and dimensions were smaller in the TIC group than in the idiopathic DCMP group. Of those, LV end-diastolic dimension was the only independent predictor of TIC in multiple regression analysis (odds ratio [OR] 0.742 per 1 mm, 95% confidence ratio [CI] 0.618 to 0.891, p=0.001). The Association of University Cardiologists (AUC) was 0.908 on receiver-operating characteristic (ROC) curve analysis and LV end-diastolic dimension<or=61% mm could predict TIC with a sensitivity of 100% and a specificity of 71.4%. After restoration of sinus rhythm (n=8), one experienced recurrent TIC after discontinuation of amiodarone. After control of heart rate (n=13), one experienced recurrent TIC due to poor control of heart rate (log-rank test, p=0.808). There were no differences in the echocardiographic parameters between the 2 groups before and after treatment except for the larger initial LV volumes in the rhythm control. CONCLUSIONS: In patients presented as heart failure with tachyarrhythmia, initial echocardiographic parameters, especially LV end-diastolic dimension, help to differentiate TIC from idiopathic DCMP. Rate control was as effective as rhythm control for EF improvement and prognosis.
No takes yet. Share an insight, caveat, or question.
Jeong et al. (2008) conducted a case-control in Tachycardia-induced cardiomyopathy (n=42). Rate control vs. Rhythm control was evaluated on Prediction of TIC using LV end-diastolic dimension (OR 0.742, 95% CI 0.618-0.891, p=0.001). LV end-diastolic dimension ≤61 mm predicted tachycardia-induced cardiomyopathy versus idiopathic DCMP with 100% sensitivity and 71.4% specificity (OR 0.742 per 1 mm; 95% CI 0.618-0.891; p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: